CUV 1.60% $14.74 clinuvel pharmaceuticals limited

Ann: CLINUVEL Newsletter III - June 2024, page-32

  1. 594 Posts.
    lightbulb Created with Sketch. 281
    I now see that Palatin has commenced a P2 trial for ED (n=50, topline results 6/12). Palatin are trialling MT2 for ED and weight loss. both in combination with PDE5i and GLP1 drugs. Weight loss, frying pan handle boners, if only there was a way of getting a tan. The ultimate barbie drug.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.74
Change
-0.240(1.60%)
Mkt cap ! $738.1M
Open High Low Value Volume
$14.99 $15.02 $14.61 $887.1K 59.91K

Buyers (Bids)

No. Vol. Price($)
1 88 $14.68
 

Sellers (Offers)

Price($) Vol. No.
$14.74 6 1
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.